[1]
Shabeeb, Z.A., Faraj, Y.F., Mtashar, B.A., Hussein, M.S. and Hasan, A.F. 2025. Immune-biomarker signature predicts early molecular response in Iraqi chronic myeloid leukemia patients receiving front-line tyrosine-kinase inhibitors. Regulatory Mechanisms in Biosystems. 16, 4 (Dec. 2025), e25197. DOI:https://doi.org/10.15421/0225197.